Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
macrocycles
Biotech
Syneron closes $150M round to support peptide platform
Peptide drug discovery company Syneron Bio closed a $150 million series B round to support its macrocyclic peptide development platform.
Will Maddox
Apr 3, 2026 9:31am
Merck dives into data showing PCSK9 pill easily outswims rivals
Mar 30, 2026 11:45am
Novartis finds natural partnership in macrocycle biotech
Feb 18, 2026 10:13am
Argenx's $1.5B pact to turn macrocyclic peptides to new targets
Jul 1, 2025 8:00am
Macrocyclic peptides preserve muscle in mice given semaglutide
Dec 12, 2024 12:45pm
Merck & Co. signs $220M macrocyclic peptide deal
Jan 23, 2024 9:00am
